Kevin Louis

The AJT April issue is now online! amjtransplant.org/current

Or second April Editor's Choice article is "High-dimensional profiling of immune responses to kidney transplant reveals heterogeneous T helper 1 and B cell effectors associated with rejection" by Louis et al. doi.org/10.1016/j.ajt.… #kidneytransplant

🎉 Congrats to the Singapore research team on ezSingleCell! 🎉 A game-changer for #singlecell & #spatialbiology, it simplifies data analysis from platforms like Chromium, Visium & Xenium without programming expertise! 🚀 Learn more: nature.com/articles/s4146…

The discovery of the APOL1 risk variants and their impact, in a autosomal recessive fashion, on the disproportionate rate of kidney disease affecting individuals of African ancestry revolutionized the field of nephrology. In this perspective, the authors assert that nearly 15 years from the first report of APOL1 implications for kidney disease, the H3Africa-KDRN landmark study now finally provides us with significant insights from the population where the G1 and G2 variants arose and co-evolved with humans, providing critical insights into the complex interplay of genetics, environment, and health disparities within West African populations. bit.ly/JASN0587 @opeyemiolabisi8 @SannaCherchiLab

@dommibertrand @GroupeSpiesser Congratulation @dommibertrand and team! And Great presentation at @SFTfrancophone symposium

🚨🚨🚨So happy to share our multicentric study about the risk of TCMR after belatacept rescue conversion 🛟 in a large cohort of KT recipients. Many thanks 🙏 to my friends from the ⁦@GroupeSpiesser⁩ ! frontierspartnerships.org/journals/trans…

Great presentations at ENGAGE II dissemination session today ! Lively discussions on center practices and optimal management of sensitized patients. @ESOTtransplant @OriolBestard @Olivier_Thaunat @mnaesens @CDudreuilh @CallemeynJasper @ParisTxGroup

Excellent workshop organised by @ESOTtransplant with 21 countries represented. Looking forward to tomorrow and paving the way for consensus in managing highly sensitised patients!

@Lucreziafurian @XCharmetant @KoenigAlice1 @SFTfrancophone @SFTJuniors @KervellaD Interactive case studies illustrating Desensitization and Immunomodulation strategies based on patient risk

@Lucreziafurian @XCharmetant @KoenigAlice1 @SFTfrancophone @SFTJuniors @KervellaD

[ 📰 Publication dans le @NEJM ] 🔎 Une vaste étude internationale a été conduite à l'institut PITOR (Paris Institute for Transplantation and Organ Regeneration - @Inserm U970, @univ_paris_cite ) incluant plus de 16000 biopsies réalisées chez 7000 patients transplantés rénaux

"High-dimensional profiling of immune responses to kidney transplant reveals heterogeneous T helper 1 and B cell effectors associated with rejection" by Louis et al. is recently published online in press: doi.org/10.1016/j.ajt.… @Kevin_JLouis @univ_paris_cite @InstituteStarzl

Borrowed from @Nephtales #nephsky 🦋 As @TheLancet says “Nephrology is not for normal doctors” ❤️💙 thelancet.com/action/showPdf…

How do SGLT2i works? #KidneyWk

The Simultaneously published articles on @JASN_News presented at @ASNKidney #kidneywk podcast is out Featuring three papers showing advances in IgA nephropathy podcasts.apple.com/us/podcast/jou…

📢 Just published in @NEJM and presented at @ASNKidney #KidneyWk: Our study, analyzing over 16,000 biopsies from 30+ centers, provides insight into microvascular inflammation in kidney allografts. @AlexandreLoupy 🙌 to @MartaSablik @A_Sannier @Raynaud_Maths Let’s dive into it 👇

Join us for an insightful webinar 👉 RNA interference, from basic biological concept to therapeutic revolution(s) 🗓️ 12 November ⏰ 17:30 CEST @Olivier_Thaunat @Paulo_MartinsMD ,Julianna Buchwald ,Anastasia Khvorova, @emilythompson88, Anne-Laure Leclerc go.esot.org/rna_interferen…

Découvrez les résultats de l'étude européenne EU-TRAIN qui consistait à étudier l'utilisation de biomarqueurs non invasifs dans le suivi du rejet en transplantation rénale ⬇ Cette étude a été menée par les équipes de @univ_paris_cite, @hopital_necker, @HopSaintLouis, @Inserm

A new vision of TCMR in KTx with analysis of more than 500 cases! Follow up biopsies post rejection may help clinician for risk assessment. Great multicentric effort #tts2024 @ttsorg @OriolBestard @Olivier_Thaunat @InstituteStarzl @AravindCheruku1 @KAD__MD

Very nice presentations today at #tts2024 in the transplant immunosuppression and biomarker session. Exciting new therapeutics and biomarkers under development! @ParisTxGroup @RotterdamTrans @BaanCarla @DimitriBedo @ilies_benotmane